Okuno, K.; Xu, C.; Pascual-Sabater, S.; Tokunaga, M.; Han, H.; Fillat, C.; Kinugasa, Y.; Goel, A.
Berberine Overcomes Gemcitabine-Associated Chemoresistance through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic Ductal Adenocarcinoma. Pharmaceuticals 2022, 15, 1199.
https://doi.org/10.3390/ph15101199
AMA Style
Okuno K, Xu C, Pascual-Sabater S, Tokunaga M, Han H, Fillat C, Kinugasa Y, Goel A.
Berberine Overcomes Gemcitabine-Associated Chemoresistance through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic Ductal Adenocarcinoma. Pharmaceuticals. 2022; 15(10):1199.
https://doi.org/10.3390/ph15101199
Chicago/Turabian Style
Okuno, Keisuke, Caiming Xu, Silvia Pascual-Sabater, Masanori Tokunaga, Haiyong Han, Cristina Fillat, Yusuke Kinugasa, and Ajay Goel.
2022. "Berberine Overcomes Gemcitabine-Associated Chemoresistance through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic Ductal Adenocarcinoma" Pharmaceuticals 15, no. 10: 1199.
https://doi.org/10.3390/ph15101199
APA Style
Okuno, K., Xu, C., Pascual-Sabater, S., Tokunaga, M., Han, H., Fillat, C., Kinugasa, Y., & Goel, A.
(2022). Berberine Overcomes Gemcitabine-Associated Chemoresistance through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic Ductal Adenocarcinoma. Pharmaceuticals, 15(10), 1199.
https://doi.org/10.3390/ph15101199